Primary record
1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-
- 库存
- 1,179 克
- 纯度
- 98.9 %
- CAS
- 1223403-58-4
化合物标识与属性
- CAS
- 1223403-58-4
- PubChem CID
- 46188928
- SMILES
- C1C[C@@H](N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CC[C@@H](C4)O)C5=C(C=CC(=C5)F)F
- Canonical SMILES
- O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1
名称与同义词
- Larotrectinib
- LOXO-101
- 1223403-58-4
- Vitrakvi
- LarotrectinibFor
- larotrectinibum
- ARRY-470
- Larotrectinib sulfate
- Larotrectinib [INN]
- LOXO 101
- LOXO101
- RefChem:57159
- Larotrectinib (Standard)
- ARRY 470
- PF9462I9HX
- ARRY470
- LAROTRECTINIB [MI]
- ARRY-470; larotrectinib
- Larotrectinib (USAN/INN)
- Larotrectinib [USAN:INN]
- LAROTRECTINIB [USAN]
- UNII-PF9462I9HX
- BAY2757556
- C21H22F2N6O2
- BAY-2757556
- LAROTRECTINIB [WHO-DD]
- MFCD28902192
- AMY264
- DTXSID101020707
- GTPL8909
- orb1301362
- SCHEMBL2241012
- CHEMBL3889654
- SCHEMBL29420193
- L01XE53
- NYNZQNWKBKUAII-KBXCAEBGSA-N
- ARR Y 470
- BDBM136597
- DTXCID001493220
- GLXC-90513
- Larotrectinib (LOXO-101 free base)
- BCP16262
- EX-A1981
- (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
- EBC-17104
- HY-12866R
- NSC785570
- NSC801004
- s5860
- LOXO-101 (ARRY-470)
- AKOS027338709
- example 14 [US8865698 B2]
- ZINC118399834
- ACN-043424
- CS-5722
- DB14723
- NSC-785570
- NSC-801004
- AC-33660
- AS-35231
- BP-43662
- FD145150
- HY-12866
- (r)-2-(2-chloro-5-fluorophenyl)pyrrolidine
- NS00133777
- J3.628.138C
- D11137
- EN300-7411765
- US8865698, 14
- A857935
- (3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide
- 1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-
- BRD-K36574127-001-01-3
- Q27081513
- (3S)-N-{5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl}-3-hydroxypyrrolidine-1-carboxamide
- 1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-
- ARRY-470;ARRY 470 : LOXO-101; LOXO101; Larotrectinib
- ARRY470;ARRY-470;ARRY 470;LOXO 101;LOXO101;Larotrectinib
- (3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide
- (3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-pyrrolidine-1-carboxamide
- (3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-1-pyrrolidinecarboxamide
- (3S)-N-(5-((2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN- 1-YL)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE- 1-CARBOXAMIDE
- (3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine- 1-carboxamide
- (3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
- (3S)-N-(5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
- (3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]-pyrazolo[1,5-a]pyrimidine-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide
- (S)-N-(5 -((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
- (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin -1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
- (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
- (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3 yl)-3-hydroxypyrrolidine-1-carboxamide
- 1223405-13-7
- 3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
- 826-190-2